Home > Insider Trading > Filing (0001567619-21-021902)

Filing Details

Accession Number:: 0001567619-21-021902
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-10 18:50:07
Reporting Period:: 2021-12-01

Accepted Time:: 2021-12-10 18:50:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1717452	Odonate Therapeutics Inc.	ODT	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587114	Ecor1 Capital, Llc	357 Tehama Street #3 San Francisco CA 94103		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-01	185,941	$1.66	5,701,669	No	4	P	Indirect	See Note 1
Common Stock	Disposition	2021-12-01	185,941	$1.66	5,701,669	No	4	S	Indirect	See Note 1
Common Stock	Disposition	2021-12-09	156,669	$1.82	5,545,000	No	4	S	Indirect	See Note 1
Common Stock	Disposition	2021-12-10	5,000,000	$1.66	545,000	No	4	S	Indirect	See Note 1
Common Stock	Disposition	2021-12-10	545,000	$1.55	0	No	4	S	Indirect	See Note 1

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Note 1
No	4	S	Indirect	See Note 1
No	4	S	Indirect	See Note 1
No	4	S	Indirect	See Note 1
No	4	S	Indirect	See Note 1

Footnotes

The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds held these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owned them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owned them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
These securities were transferred from another Fund managed by EcoR1 to Qualified Fund as part of a periodic rebalancing of the portfolios of the Funds. After this transaction, Qualified Fund held 5,185,698 shares of the Issuer's Common Stock, and the other fund held 515,971 shares.
Qualified Fund sold 142,491 of these shares. After this transaction, Qualified Fund held 5,043,207 shares of the Issuer's Common Stock.
Qualified Fund sold 4,547,500 of these shares. After this transaction, Qualified Fund held 495,707 shares of the Issuer's Common Stock.
Qualified Fund sold 495,707 of these shares. After this transaction, Qualified Fund held no shares of the Issuer's Common Stock.